Back to mobile site

Amgen (AMGN) PT Raised to $175 at Oppenheimer

February 3, 2017 6:21 AM EST Send to a Friend
Oppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $175.00 (from $166.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login